Literature DB >> 34374484

Serological tests for COVID-19: Potential opportunities.

Marcarious M Tantuoyir1,2,3, Nima Rezaei1,4,5.   

Abstract

Entities:  

Keywords:  IgG; IgM; SARS-CoV-2; antibody; coronavirus; diagnosis

Mesh:

Substances:

Year:  2021        PMID: 34374484      PMCID: PMC8426956          DOI: 10.1002/cbin.11686

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   4.473


× No keyword cloud information.
In response to the commentary article about our recent publication in Cell Biology International (https://doi.org/10.1002/cbin.11516), which states that Hemagglutinin‐esterase protein is absent in SARS‐Cov2 as reported in Table 2 of our publication, we acknowledge the error and seek for correction. This is largely due to the uncertainties and discoveries about the SARS‐COV‐2 virus. However, the information provided in our publication was validated by Ravi et al. (2020) but upon critical consideration and extensive reviews of the viral structural proteins, the Hemagglutinin‐esterase protein is absent in the SARS‐COV‐2 viral structure (Astuti & Ysrafil, 2020; Yin, 2020). Therefore, the following correction should be made accordingly:
Table 2

A summary of SARS‐CoV‐2 structural proteins, binding sites, and their roles (Astuti & Ysrafil, 2020)

Protein NameBinding mechanismRole
Spike protein (S)Utilizes an N‐terminal signal sequence to gain access to the ER (endoplasmic reticulum)Mediates attachment to host receptors
Nucleocapsid protein (N)Binds the viral genome in a beads‐on‐a‐string type conformationTethers the viral genome to replicase‐transcriptase complex, packages the encapsulated genome into viral particles
Envelope protein (E)A transmembrane protein with ion channel activityFacilitates assembly and release of the virus; involved in ion channel activity
Membrane protein (M)Binds to nucleocapsidPromotes membrane curvature
A summary of SARS‐CoV‐2 structural proteins, binding sites, and their roles (Astuti & Ysrafil, 2020)
  4 in total

Review 1.  Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape.

Authors:  Neeraja Ravi; Dana L Cortade; Elaine Ng; Shan X Wang
Journal:  Biosens Bioelectron       Date:  2020-07-18       Impact factor: 10.618

2.  Genotyping coronavirus SARS-CoV-2: methods and implications.

Authors:  Changchuan Yin
Journal:  Genomics       Date:  2020-04-27       Impact factor: 5.736

Review 3.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.

Authors:  Indwiani Astuti
Journal:  Diabetes Metab Syndr       Date:  2020-04-18

4.  Serological tests for COVID-19: Potential opportunities.

Authors:  Marcarious M Tantuoyir; Nima Rezaei
Journal:  Cell Biol Int       Date:  2021-08-24       Impact factor: 4.473

  4 in total
  2 in total

Review 1.  COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review.

Authors:  SeyedAhmad SeyedAlinaghi; Amirali Karimi; Alireza Barzegary; Hengameh Mojdeganlou; Farzin Vahedi; Seyed Peyman Mirghaderi; Parnian Shobeiri; Maryam Ramezani; Parisa Yousefi Konjdar; Pegah Mirzapour; Marcarious M Tantuoyir; Esmaeil Mehraeen; Omid Dadras; Fabricio Voltarelli
Journal:  Eur J Med Res       Date:  2022-10-08       Impact factor: 4.981

2.  Serological tests for COVID-19: Potential opportunities.

Authors:  Marcarious M Tantuoyir; Nima Rezaei
Journal:  Cell Biol Int       Date:  2021-08-24       Impact factor: 4.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.